Personal information

No personal information available

Activities

Collapse all

Works (5)

Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer

Investigational New Drugs
2021-04 | Journal article
DOI: 10.1007/s10637-020-01032-y
Contributors: Bartosz Mateusz Gąsiorkiewicz; Paulina Koczurkiewicz-Adamczyk; Kamil Piska; Elżbieta Pękala
Source: check_circle
Crossref

Recent Progress in Discovering the Role of Carotenoids and Their Metabolites in Prostatic Physiology and Pathology with a Focus on Prostate Cancer—A Review—Part I: Molecular Mechanisms of Carotenoid Action

Antioxidants
2021-04-10 | Journal article
DOI: 10.3390/antiox10040585
Contributors: Joanna Dulińska-Litewka; Yoav Sharoni; Przemysław Hałubiec; Agnieszka Łazarczyk; Oskar Szafrański; James A. McCubrey; Bartosz Gąsiorkiewicz; Piotr Laidler; Torsten Bohn
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

The role of oxidative stress in the etiology of selected civilization diseases

Farmacja Polska
2021-03-26 | Journal article
DOI: 10.32383/farmpol/134797
Contributors: Paulina Koczurkiewicz-Adamczyk; Bartosz Gąsiorkiewicz; Elżbieta Pękala; Patrycja Bojdo
Source: check_circle
Crossref

Recent Progress in Discovering the Role of Carotenoids and Metabolites in Prostatic Physiology and Pathology-A Review-Part II: Carotenoids in the Human Studies.

Antioxidants (Basel, Switzerland)
2021-02-20 | Journal article
DOI: 10.3390/antiox10020319
PMID: 33672578
PMC: PMC7924028
Source: Self-asserted source
Bartosz Gąsiorkiewicz
grade
Preferred source (of 2)‎

Could the kinetin riboside be used to inhibit human prostate cell epithelial–mesenchymal transition?

Medical Oncology
2020-03 | Journal article
DOI: 10.1007/s12032-020-1338-1
Part of ISSN: 1357-0560
Part of ISSN: 1559-131X
Source: Self-asserted source
Bartosz Gąsiorkiewicz
How many people are using ORCID?